Showing results (141-150 of 372) with videos related to
Sort By:
Pageof 38
Anticancer Research|March 8, 2011
Influencing the Wnt signaling pathway in multiple myelomaYoung Kim, Guido Reifenberger, Desheng Lu, et al.Journal of Proteome Research|August 9, 2011
Choice of biological source material supersedes oxidative stress in its influence on DJ-1 in vivo interactions with Hsp90Christiane B Knobbe, Timothy J Revett, Yu Bai, et al.Clinical Nuclear Medicine|February 28, 2023
Locoregional Treatment of Glioblastoma With Targeted α Therapy: [ 213 Bi]Bi-DOTA-Substance P Versus [ 225 Ac]Ac-DOTA-Substance P-Analysis of Influence ParametersLeszek Królicki, Jolanta Kunikowska, Frank Bruchertseifer, et al.BMC Neurology|May 28, 2010
Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhageChristian Zweifel, Mira Katan, Philipp Schuetz, et al.EMBO Molecular Medicine|December 8, 2011
The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesisIris Augustin, Violaine Goidts, Angelika Bongers, et al.The American Journal of Pathology|August 26, 2003
Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reactionJörg van den Boom, Marietta Wolter, Rork Kuick, et al.Neuro-Oncology|July 24, 2013
Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δAlexander Schulte, Katrin Liffers, Annegret Kathagen, et al.Cancer Research|March 17, 2011
MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastomaMichal Grzmil, Pier Morin, Maria Maddalena Lino, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2021
Dose escalation study of targeted alpha therapy with [225Ac]Ac-DOTA-substance P in recurrence glioblastoma - safety and efficacyLeszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.Pageof 38